CTRI/2023/02/049866
Not yet recruiting
Phase 2
Safety and efficacy of fasting therapyamong type 2 diabetes mellitus patients: Randomizedcontrol trial.
Sant Hirdaram yoga and nature cure hospital0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Sant Hirdaram yoga and nature cure hospital
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Type 2 diabetes mellitus
- •Age between 35 to 65 years
- •Willing to fast and give consent
Exclusion Criteria
- •Any type of Diabetes related complications like nephropathy, retinopathy and neuropathy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 1
Study for safety and efficacy of fasting therapy of metabolic syndromeITMCTR1900002845Sichuan Hospital of Integrated Chinese and Western Medicine
Not yet recruiting
Not Applicable
Study to observe the safety of fasting and improvement in aging indices in healthy adultsJPRN-UMIN000052921Juntendo University80
Recruiting
Not Applicable
Safety and efficacy of intermittent fasting and exercise in overweight people with type 2 diabetes – a randomized controlled trialE11Type 2 diabetes mellitusDRKS00032036Medizinische Universität Graz80
Terminated
Not Applicable
Biweekly Interval Intermittent Fasting for Type 2 Diabetes, a Safety StudyDiabetes Type 2Pre-diabetesNCT03938441gino gaddini24
Not yet recruiting
Phase 2
Therapeutic Fasting for Primary DysmenorrheaHealth Condition 1: N944- Primary dysmenorrheaCTRI/2021/09/036587Sant Hirdaram Medical College of Naturopathy and Yogic Sciences for women Bhopal